Skip to content
Research Article Open access CC BY 4.0

Antibacterial Screening and Analysis of Streptomyces coelicolor Secondary Metabolites

Aqeel Ismael Gheni, Ayad H. Hasan

Journal of Pharmaceutical Research International · pp. 26–39 · Published 5 Feb 2022

10.9734/jpri/2022/v34i7B35469

Abstract

Aims: The widespread usage of commercially accessible antibacterial agents has resulted in the emergence of multidrug-resistant bacterial pathogens worldwide. Streptomycetes produce a variety of antibacterial secondary metabolites and the study, as a result, will look into the antibacterial potential of Streptomyces coelicolor against some pathogenic bacteria. Place and Duration of Study: The study was based at the department of Medical Microbiology, Science and Health research center, Faculty of science and health, Koya University. between April, 2019 and December, 2020. Methodology: The Streptomyces coelicolor strains in this study were verified phenotypically via tryptone soya agar in addition to their genotype using three different sets of primers. Afterwards, Thin Layer Chromatography (TLC) was utilised to purify actinorhodin from the crude extract of S. coelicolor secondary metabolites. The antibacterial activities of the actinorhodin and the crude extract have further been tested against standard strains of Staphylococcus aureus (ATCC 25923), Streptococcus pyogenes (ATCC 19165), Escherichia coli (ATCC 25218), and Salmonella typhi (ATCC 14028). Disc diffusion and minimum inhibitory concentration (MIC) techniques were both used to serve this purpose. Results: A significant activity of the organic solvent extract was observed against Staphylococcus aureus and Streptococcus pyogenes using the disc diffusion method with diameter zone inhibition of (9-20 mm) and (11-23 mm), respectively. Actinorhodin, on the other hand, showed a reasonable wider effect against them with diameter zone inhibition of (10-24 mm) against S. aureus and (10-27 mm) against S. pyogenes. Comparatively, the MIC test showed akin results by inhibiting S. aureus and S. pyogenes at a MIC value of 16 µg/ml using crude extract. Whereas actinorhodin expressed greater inhibitory activities against S. aureus, S. pyogenes and S. typhi with MICs of (8, 16 and 32 µg/ml), respectively. Conclusion: The capability of suggested actinorhodin from the L646 strain to inhibit Staphylococcus aureus and Streptococcus pyogenes growth with a MIC value of 8 g/ml was a remarkable finding obtained by studying Streptomyces coelicolor secondary metabolites.

Crude extract Streptomyces coelicolor TLC actinorhodin MIC

References (27)

  1. 1 Practical streptomyces genetics
  2. 2 Taxonomy, Physiology, and Natural Products of Actinobacteria [DOI]
  3. 3 How many antibiotics are produced by the genus Streptomyces ? [DOI]
  4. 4 LPSN – List of Prokaryotic names with Standing in Nomenclature (bacterio.net), 20 years on [DOI]
  5. 5 Renaissance in antibacterial discovery from actinomycetes [DOI]
  6. 6 Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically
  7. 7 Streptomyces as symbionts: an emerging and widespread theme? [DOI]
  8. 8 Actinobacteria from Arid and Desert Habitats: Diversity and Biological Activity [DOI]
  9. 9 Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? [DOI]
  10. 10 An efficient approach for screening minimal PKS genes from Streptomyces [DOI]
  11. 11 Notes from the Field : Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016 [DOI]
  12. 12 Antibiotic drug discovery [DOI]
  13. 13 Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria [DOI]
  14. 14 Actinorhodin is a Chromosomally-determined Antibiotic in Streptomyces coelicolor A3(2) [DOI]
  15. 15 Production of Specialized Metabolites by Streptomyces coelicolor A3(2) [DOI]
  16. 16 Screening of Actinomycete Isolates from Niche Habitats in Manipur for Antibiotic Activity [DOI]
  17. 17 Actinorhodin is a redox‐active antibiotic with a complex mode of action against G ram‐positive cells [DOI]
  18. 18 Multi-level regulation of coelimycin synthesis in Streptomyces coelicolor A3(2) [DOI]
  19. 19 Anti-microbial activity of chrysomycin A produced by Streptomyces sp. against Mycobacterium tuberculosis [DOI]
  20. 20 Bioactive phthalate from marine Streptomyces ruber EKH2 against virulent fish pathogens [DOI]
  21. 21 Screening of Marine Actinobacteria for Antimicrobial Compounds [DOI]
  22. 22 Genetics of Antibiotic Production in Streptomyces coelicolor A3(2), a Model Streptomycete [DOI]
  23. 23 Biochemical studies on antibiotic production from Streptomyces sp.: Taxonomy, fermentation, isolation and biological properties [DOI]
  24. 24 Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli [DOI]
  25. 25 Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of γ-actinorhodin [DOI]
  26. 26 Production, purification and characterization of an antimicrobial compound from marine Streptomyces coeruleorubidus BTSS-301 [DOI]
  27. 27 The Gene Encoding RNase III in Streptomyces coelicolor Is Transcribed during Exponential Phase and Is Required for Antibiotic Production and for Proper Sporulation [DOI]

Cited by 3

Microbial Pigments: Fermentative Production and Biological Activities

Chi-Ching Lee · Sustainable Landscape Planning and Natural Resources Management · 2025

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.